The global Non-opioid Pain Patch market size is predicted to grow from US$ 685 million in 2025 to US$ 803 million in 2031; it is expected to grow at a CAGR of 2.7% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

A non-opioid pain patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

United States market for Non-opioid Pain Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Non-opioid Pain Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Non-opioid Pain Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Non-opioid Pain Patch players cover Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

Infinity Market Research newest research report, the Non-opioid Pain Patch Industry Forecast looks at past sales and reviews total world Non-opioid Pain Patch sales in 2024, providing a comprehensive analysis by region and market sector of projected Non-opioid Pain Patch sales for 2025 through 2031. With Non-opioid Pain Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-opioid Pain Patch industry.

This Insight Report provides a comprehensive analysis of the global Non-opioid Pain Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-opioid Pain Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Non-opioid Pain Patch market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-opioid Pain Patch and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-opioid Pain Patch.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-opioid Pain Patch market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Lidocaine Patches
    Diclofenac Patches
    Indomethacin Patches
    Counter-Irritant Patches
    Fentanyl Patches
    Others

Segmentation by Application:

    OTC
    Rx

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Hisamitsu
    Mylan
    Johnson & Johnson
    Actavis
    Lingrui
    Teikoku Seiyaku
    Sanofi
    Novartis
    Qizheng
    Endo
    Huarun 999
    GSK
    Haw Par
    Nichiban
    Mentholatum
    Laboratoires Genevrier
    BLUE-EMU

Key Questions Addressed in this Report

What is the 10-year outlook for the global Non-opioid Pain Patch market?
What factors are driving Non-opioid Pain Patch market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-opioid Pain Patch market opportunities vary by end market size?
How does Non-opioid Pain Patch break out by Type, by Application?